Huaxi Bio controlling shareholder completes share increase plan, exceeds minimum target

Huaxi Biotechnology Co., Ltd. (Huaxi Bio) announced today that its controlling shareholder, Huaxi Xinyu Investment Co., Ltd., has completed its previously disclosed share increase plan. The plan, which commenced on August 27, 2025, and concluded on September 30, 2025, saw Huaxi Xinyu accumulate 4,518,703 shares of Huaxi Bio through concentrated bidding transactions on the Shanghai Stock Exchange.

The total amount invested reached CNY 257,478,738.40, surpassing the lower end of the proposed investment range of CNY 200,000,000. This increment represents 0.94% of Huaxi Bio's total share capital. The initial plan, disclosed on August 8, 2025, aimed for an investment between CNY 200,000,000 and CNY 300,000,000, not exceeding 1% of the company's total share capital and with a share price not exceeding CNY 70 per share.

Following the completion of this plan, Huaxi Xinyu and its consistent action parties now collectively hold 289,513,346 shares, representing 60.11% of Huaxi Bio's total share capital. The company affirmed that the completion of the share increase plan will not impact the company's listing status or equity distribution, nor cause changes in the controlling shareholder, actual controller, governance structure, or ongoing operations.